Effective management of canine hypercortisolism requires more than selecting the right diagnostic test, it demands careful interpretation of clinical findings and ongoing assessment of treatment response. In this practical, case-focused session, participants will review the spectrum of clinical signs associated with Cushing's disease, including less obvious presentations that can delay diagnosis. The session also examines the strengths and limitations of commonly used diagnostic tests, including low-dose dexamethasone suppression testing and ACTH stimulation testing, and discusses when each is most appropriate.
Building on the diagnostic foundation, the presentation explores evidence-based use of trilostane for managing hyperadrenocorticism. Topics include dosing strategies, monitoring clinical improvement, recognizing treatment complications, and interpreting pre-medication plasma cortisol concentrations as part of patient monitoring. Attendees will leave with practical, immediately applicable strategies to diagnose, monitor, and manage canine hypercortisolism with greater confidence.
